Baird Medical Investment Holdings Limited (BDMD)
After hours:
- PR Newswire
Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress
Baird Medical, (NASDAQ: BDMD) a global leader in minimally invasive microwave ablation (MWA) technology, successfully participated in the prestigious 2024 American College of Surgeons (ACS) Clinical Congress held at the renowned Moscone Center in San Francisco. This year's congress attracted over 10,000 attendees, including 7,000 surgeons from around the world, making it one of the largest surgical events globally.
- PR Newswire
Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medical devices in China, which recently expanded into the U.S. market following its U.S. FDA 510(k) clearances, today announced its participation in the upcoming American Thyroid Association (ATA) Annual Meeting. The event is scheduled to take place from October 30 to November 3, 2024, at the Sheraton Grand Chicago Riverwalk in Chicago, Illinoi
